RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,006,592 | -66.0% | 657,899 | 0.0% | 0.25% | -66.7% |
Q1 2024 | $5,907,933 | -63.9% | 657,899 | 0.0% | 0.76% | -58.9% |
Q4 2023 | $16,348,790 | -25.2% | 657,899 | -50.0% | 1.84% | -22.9% |
Q3 2023 | $21,868,562 | +104.7% | 1,315,798 | +130.3% | 2.39% | -13.1% |
Q2 2023 | $10,682,057 | +34.5% | 571,233 | +32.0% | 2.74% | -60.6% |
Q1 2023 | $7,943,715 | -7.3% | 432,900 | 0.0% | 6.97% | -13.1% |
Q4 2022 | $8,571,420 | -17.7% | 432,900 | 0.0% | 8.02% | -17.1% |
Q3 2022 | $10,416,000 | +31.8% | 432,900 | 0.0% | 9.67% | +43.9% |
Q2 2022 | $7,900,000 | -17.0% | 432,900 | 0.0% | 6.72% | +21.5% |
Q1 2022 | $9,519,000 | -40.1% | 432,900 | 0.0% | 5.53% | -38.8% |
Q4 2021 | $15,900,000 | -19.4% | 432,900 | -31.8% | 9.04% | -5.7% |
Q3 2021 | $19,722,000 | -15.7% | 635,177 | -13.7% | 9.59% | +26.3% |
Q2 2021 | $23,391,000 | +43.2% | 735,801 | 0.0% | 7.59% | +38.9% |
Q1 2021 | $16,335,000 | +12.4% | 735,801 | 0.0% | 5.46% | +77.7% |
Q4 2020 | $14,532,000 | – | 735,801 | – | 3.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $53,076,296 | 17.67% |
Euclidean Capital LLC | 432,900 | $8,571,420 | 8.02% |
GREAT POINT PARTNERS LLC | 1,436,569 | $28,444,066 | 5.58% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 880,000 | $17,424,000 | 3.47% |
Trustees of Columbia University in the City of New York | 73,383 | $1,453 | 3.00% |
Cheyne Capital Management (UK) LLP | 71,828 | $1,422,194 | 2.48% |
Deep Track Capital, LP | 1,304,940 | $25,837,812 | 1.08% |
Ghost Tree Capital, LLC | 125,000 | $2,475,000 | 1.06% |
Perceptive Advisors | 1,798,955 | $35,619,309 | 1.00% |
BRAIDWELL LP | 1,000,000 | $19,800,000 | 0.66% |